Yale Journal on Regulation Notice & Comment
Media
September 9, 2024 / Published Work
Fifth Circuit Review – Reviewed: The agency losing streak under Loper Bright continues
August 19, 2024 / Media Mention
Shane Pennington quoted in Law360 article about psilocybin being used to treat a terminally ill patient
Law360
August 13, 2024
Fifth Circuit Review – Reviewed: Nondelegation bonanza
Yale Journal on Regulation Notice & Comment
July 23, 2024 / Media Mention
43,000 Comments Filed on Cannabis Rescheduling Proposal as Public Period Closes
Cannabis Business Times
July 10, 2024 / Media Mention
US House Republicans nix states’ rights Cannabis amendment, focus on blocking rescheduling
Cannabis Business Times
July 2, 2024 / Media Mention
How will Supreme Court ruling affect marijuana rescheduling?
MJBiz Daily
April 30, 2024 / Media Mention
Cannabis Rescheduling Update: Is a ‘Notoriously Secretive Agency’ Now Involved?
Cannabis Business Times
April 30, 2024 / Media Mention
Cannabis Rescheduling: Rumours Swirl on Imminent DEA Announcement as Legal Experts Expected to Weigh In
Business of Cannabis
April 30, 2024 / Media Mention
DEA signs off on marijuana rescheduling, report says, but process not done yet
MJBiz Daily
April 27, 2024 / Media Mention
Shane Pennington quoted in Washington Post article on MDMA research as a mental health treatment
The Washington Post
March 19, 2024 / Media Mention
DEA’s 5-factor test makes rescheduling cannabis impossible
Cannabis Business Times
February 29, 2024 / Media Mention
Shane Pennington quoted in Washington Post article on cannabis research in Michigan
Washington Post
February 14, 2024 / Media Mention
DEA, Attorney General miss deadline to respond to 12 US Senators on cannabis rescheduling
Cannabis Business Times
February 13, 2024 / Media Mention
Moving marijuana to Schedule III would not violate international treaties, legal opinion says
Marijuana Moment
February 12, 2024 / Media Mention
Will a court ruling push the DEA to reschedule Psilocybin?
Medscape UK
February 8, 2024 / Media Mention
Congressman presses DEA for answers on ongoing Cannabis scheduling review
Cannabis Business Times
January 31, 2024 / Press Release
Weil Brown expands Washington office, government affairs practice
January 16, 2024 / Media Mention
These cannabis stocks and ETFs stand to benefit if the Biden administration reforms marijuana laws
MarketWatch | Dow Jones
January 16, 2024 / Media Mention
FDA recommends DEA move Cannabis from Schedule I to III
Medscape Medical News
January 4, 2024 / Media Mention
Industry attorney weighs in on possible Cannabis rescheduling timeline: ‘It normally takes years and years for this to get done’
Cannabis Business Times
January 1, 2024 / Media Mention
Shane Pennington featured in Law360 article on rescheduling cannabis in 2024
Law360
November 27, 2023 / Law Alert
Ohio’s cannabis industry awaiting Issue 2 changes
October 25, 2023 / Published Work
Moving marijuana to Schedule III would aid access to legal care
Bloomberg Law
September 20, 2023 / Media Mention
National Law Review, Missouri Business quotes Shane Pennington regarding marijuana rescheduling
National Law Review
September 14, 2023 / Media Mention
Cannabis Business Times features Shane Pennington in Q&A and webinar about cannabis descheduling
Cannabis Business Times
- Page 1 of 2
